Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathryn M Cranston

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Translational Research : the Journal of Laboratory and Clinical Medicine|September 15, 2015
Using patient-specific induced pluripotent stem cells to interrogate the pathogenicity of a novel retinal pigment epithelium-specific 65 kDa cryptic splice site mutation and confirm eligibility for enrollment into a clinical gene augmentation trialBudd A Tucker, Cathryn M Cranston, Kristin A Anfinson, et al.
Current Protocols in Stem Cell Biology|August 15, 2017
Generation of Xeno-Free, cGMP-Compliant Patient-Specific iPSCs from Skin BiopsyLuke A Wiley, Kristin R Anfinson, Cathryn M Cranston, et al.
Stem Cell Research|April 10, 2017
Patient-specific induced pluripotent stem cells to evaluate the pathophysiology of TRNT1-associated Retinitis pigmentosaTasneem P Sharma, Luke A Wiley, S Scott Whitmore, et al.
Stem Cells Translational Medicine|April 21, 2019
Optimizing Donor Cellular Dissociation and Subretinal Injection Parameters for Stem Cell-Based TreatmentsBrittni A Scruggs, Chunhua Jiao, Cathryn M Cranston, et al.
Investigative Ophthalmology & Visual Science|January 1, 2016
Generating iPSC-Derived Choroidal Endothelial Cells to Study Age-Related Macular DegenerationAllison E Songstad, Luke A Wiley, Khahn Duong, et al.
Human Gene Therapy|July 13, 2016
Using Patient-Specific Induced Pluripotent Stem Cells and Wild-Type Mice to Develop a Gene Augmentation-Based Strategy to Treat CLN3-Associated Retinal DegenerationLuke A Wiley, Erin R Burnight, Arlene V Drack, et al.
Scientific Reports|July 30, 2016
cGMP production of patient-specific iPSCs and photoreceptor precursor cells to treat retinal degenerative blindnessLuke A Wiley, Erin R Burnight, Adam P DeLuca, et al.
Stem Cells Translational Medicine|May 6, 2017
Connective Tissue Growth Factor Promotes Efficient Generation of Human Induced Pluripotent Stem Cell-Derived Choroidal EndotheliumAllison E Songstad, Kristan S Worthington, Kathleen R Chirco, et al.
Gene Therapy|September 14, 2021
Development and biological characterization of a clinical gene transfer vector for the treatment of MAK-associated retinitis pigmentosaBudd A Tucker, Erin R Burnight, Cathryn M Cranston, et al.
The CRISPR Journal|December 18, 2023
CRISPRi-Mediated Treatment of Dominant Rhodopsin-Associated Retinitis PigmentosaErin R Burnight, Luke A Wiley, Nathaniel K Mullin, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Translational Research : the Journal of Laboratory and Clinical Medicine|September 15, 2015
Using patient-specific induced pluripotent stem cells to interrogate the pathogenicity of a novel retinal pigment epithelium-specific 65 kDa cryptic splice site mutation and confirm eligibility for enrollment into a clinical gene augmentation trialBudd A Tucker, Cathryn M Cranston, Kristin A Anfinson, et al.
Current Protocols in Stem Cell Biology|August 15, 2017
Generation of Xeno-Free, cGMP-Compliant Patient-Specific iPSCs from Skin BiopsyLuke A Wiley, Kristin R Anfinson, Cathryn M Cranston, et al.
Stem Cell Research|April 10, 2017
Patient-specific induced pluripotent stem cells to evaluate the pathophysiology of TRNT1-associated Retinitis pigmentosaTasneem P Sharma, Luke A Wiley, S Scott Whitmore, et al.
Stem Cells Translational Medicine|April 21, 2019
Optimizing Donor Cellular Dissociation and Subretinal Injection Parameters for Stem Cell-Based TreatmentsBrittni A Scruggs, Chunhua Jiao, Cathryn M Cranston, et al.
Investigative Ophthalmology & Visual Science|January 1, 2016
Generating iPSC-Derived Choroidal Endothelial Cells to Study Age-Related Macular DegenerationAllison E Songstad, Luke A Wiley, Khahn Duong, et al.
Human Gene Therapy|July 13, 2016
Using Patient-Specific Induced Pluripotent Stem Cells and Wild-Type Mice to Develop a Gene Augmentation-Based Strategy to Treat CLN3-Associated Retinal DegenerationLuke A Wiley, Erin R Burnight, Arlene V Drack, et al.
Scientific Reports|July 30, 2016
cGMP production of patient-specific iPSCs and photoreceptor precursor cells to treat retinal degenerative blindnessLuke A Wiley, Erin R Burnight, Adam P DeLuca, et al.
Stem Cells Translational Medicine|May 6, 2017
Connective Tissue Growth Factor Promotes Efficient Generation of Human Induced Pluripotent Stem Cell-Derived Choroidal EndotheliumAllison E Songstad, Kristan S Worthington, Kathleen R Chirco, et al.
Gene Therapy|September 14, 2021
Development and biological characterization of a clinical gene transfer vector for the treatment of MAK-associated retinitis pigmentosaBudd A Tucker, Erin R Burnight, Cathryn M Cranston, et al.
The CRISPR Journal|December 18, 2023
CRISPRi-Mediated Treatment of Dominant Rhodopsin-Associated Retinitis PigmentosaErin R Burnight, Luke A Wiley, Nathaniel K Mullin, et al.
Pageof 1